RAP 0.00% 20.5¢ resapp health limited

I am sure they done some internal testing before going into...

  1. 3,914 Posts.
    I am sure they done some internal testing before going into clinical trials and FDA approval process, it's quite expense and I don't think the 2.5M AUD cash at end of Q1 is enough for these processes???. I think there was also an over subscription to the CR so they could have diluted even more shares but management think this is the amount required to do what they want.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.